Clinical Trials Logo

Filter by:
NCT ID: NCT02798471 Completed - Pulmonary Embolism Clinical Trials

Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)

Start date: March 27, 2017
Phase: Phase 3
Study type: Interventional

This is an event driven Phase 3, prospective, randomized, open-label, blinded endpoint evaluation (PROBE) parallel group study in subjects with confirmed VTE. This study is designed to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) of edoxaban and to compare the efficacy and safety of edoxaban against standard of care in pediatric subjects with confirmed VTE.

NCT ID: NCT02797327 Completed - Pregnancy Clinical Trials

Molecular Signature Pregnancy

MSP
Start date: September 12, 2016
Phase:
Study type: Observational

The primary goal of the study is to identify biomarkers from the molecular signature predictive of pre-term birth. This will be achieved through high frequency sampling and profiling throughout pregnancy.

NCT ID: NCT02792218 Completed - Clinical trials for Relapsing Multiple Sclerosis

Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis

ASCLEPIOS I
Start date: September 20, 2016
Phase: Phase 3
Study type: Interventional

To compare the efficacy and safety of ofatumumab administered subcutaneously (sc) every 4 weeks versus teriflunomide administered orally once daily in patients with relapsing multiple sclerosis

NCT ID: NCT02790905 Completed - Depression Clinical Trials

Validating the Patient Health Questionnaire in Pregnant and Post-partum Migrant Women

Start date: September 2015
Phase: N/A
Study type: Observational

The objective of this study is to validate the Patient Health Questionnaire-9 (PHQ-9) and the Refugee Health Screener-15 (RHS-15) screening tools for depression in pregnant and post-partum migrant women on the Thai-Myanmar border.

NCT ID: NCT02789566 Completed - Obese Clinical Trials

Pharmacokinetic Study of Primaquine in Healthy Obese Thai Adult Subjects

PQ in Obese
Start date: August 2011
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to provide a description of the pharmacokinetic properties of primaquine and metabolites and characterize these in healthy obese Thai subjects. This is an open-label, single dose pharmacokinetic study in 10 healthy obese G6PD normal, subjects will be admitted as inpatient to receive 1 regimen for 1 visit only.

NCT ID: NCT02783794 Completed - Clinical trials for Metastatic Breast Cancer

BP-C1 in Short-term Treatment of Patients With Metastatic Breast Cancer

Start date: December 24, 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether BP-C1 is effective in the treatment of metastatic breast cancer patients who had previously received at least three lines of chemotherapy.

NCT ID: NCT02781077 Completed - Stroke Clinical Trials

Intensity of Task-Oriented Exercises

TOE
Start date: July 2016
Phase: N/A
Study type: Observational [Patient Registry]

In an observational study, the energy consumption of stroke individuals during performing the structured, progressive task-oriented exercise program for walking rehabilitation will be measured in order to confirm the intensity demand in the range of moderate to vigorous.

NCT ID: NCT02778204 Completed - HIV Infections Clinical Trials

Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection

Start date: June 5, 2017
Phase: Phase 1
Study type: Interventional

This study aimed to evaluate the safety, tolerability, and pharmacokinetics of maraviroc in infants at risk for mother-to-child HIV transmission, and to determine an appropriate dose of maraviroc during the first six weeks of life.

NCT ID: NCT02770170 Completed - Lupus Nephritis Clinical Trials

Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis

Start date: May 16, 2016
Phase: Phase 2
Study type: Interventional

The overall purpose of the study is to assess the efficacy of three different doses of BI 655064 against placebo as add-on therapy to standard of care (SOC) treatment for active lupus nephritis in order to characterize the dose-response relationship within the therapeutic range, and select the target dose for phase III development.

NCT ID: NCT02768636 Completed - Individuality Clinical Trials

Can Omega-3 Improve Heart Rate Variability Measurement?

HRV
Start date: April 2016
Phase: Phase 4
Study type: Interventional

Heart rate variability can represent physiological and psychological levels via sympathetic and parasympathetic variables on autonomic nervous function. Omega-3 has shown that it can effect on physiological and psychological with many good results. The pathways to explain about its effect had been studied in many contexts. Effect to autonomic nervous function by Omega-3 is our interesting question.